Testing effectiveness (Phase 2)Study completedNCT03499808
What this trial is testing
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Who this might be right for
Amorphous, Eosinophilic, and Acellular DepositConstipationDiarrhea+10 more
SWOG Cancer Research Network 43